Amgen 2009 Annual Report Download - page 111

Download and view the complete annual report

Please find page 111 of the 2009 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 180

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180

Exhibit No. Description
10.12+ 2002 Special Severance Pay Plan for Amgen Employees. (Filed as an exhibit to Form 10-Q for the
quarter ended June 30, 2002 on August 13, 2002 and incorporated herein by reference.)
10.13 Product License Agreement, dated September 30, 1985, and Technology License Agreement,
dated, September 30, 1985 between Amgen and Ortho Pharmaceutical Corporation. (Filed as an
exhibit to Form 10-Q for the quarter ended June 30, 2000 on August 1, 2000 and incorporated
herein by reference.)
10.14 Shareholders’ Agreement, dated May 11, 1984, among Amgen, Kirin Brewery Company, Limited
and Kirin-Amgen, Inc. (Filed as an exhibit to Form 10-K for the year ended December 31, 2000
on March 7, 2001 and incorporated herein by reference.)
10.15 Amendment No. 1 dated March 19, 1985, Amendment No. 2 dated July 29, 1985 (effective July 1,
1985), and Amendment No. 3, dated December 19, 1985, to the Shareholders’ Agreement dated
May 11, 1984. (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2000 on August 1,
2000 and incorporated herein by reference.)
10.16 Amendment No. 4 dated October 16, 1986 (effective July 1, 1986), Amendment No. 5 dated
December 6, 1986 (effective July 1, 1986), Amendment No. 6 dated June 1, 1987, Amendment
No. 7 dated July 17, 1987 (effective April 1, 1987), Amendment No. 8 dated May 28, 1993
(effective November 13, 1990), Amendment No. 9 dated December 9, 1994 (effective June 14,
1994), Amendment No. 10 effective March 1, 1996, and Amendment No. 11 effective March 20,
2000 to the Shareholders’ Agreement, dated May 11, 1984. (Filed as exhibits to Form 10-K for the
year ended December 31, 2000 on March 7, 2001 and incorporated herein by reference.)
10.17 Amendment No. 12 to the Shareholders’ Agreement, dated January 31, 2001. (Filed as an exhibit
to Form 10-Q for the quarter ended June 30, 2005 on August 8, 2005 and incorporated herein by
reference.)
10.18 Amendment No. 13 to the Shareholders’ Agreement, dated June 28, 2007 (with certain
confidential information deleted therefrom). (Filed as an exhibit to Form 10-Q for the quarter
ended June 30, 2007 on August 9, 2007 and incorporated herein by reference.)
10.19 Product License Agreement, dated September 30, 1985, and Technology License Agreement,
dated September 30, 1985, between Kirin-Amgen, Inc. and Ortho Pharmaceutical Corporation.
(Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2000 on August 1, 2000 and
incorporated herein by reference.)
10.20 Research, Development Technology Disclosure and License Agreement: PPO, dated January 20,
1986, by and between Kirin Brewery Co., Ltd. and Amgen Inc. (Filed as an exhibit to Amendment
No. 1 to Form S-1 Registration Statement on March 11, 1986 and incorporated herein by
reference.)
10.21 Amendment Agreement, dated June 30, 1988, to Research, Development, Technology Disclosure
and License Agreement: GM-CSF dated March 31, 1987, between Kirin Brewery Company,
Limited and Amgen Inc. (Filed as an exhibit to Form 8 amending the Quarterly Report on Form
10-Q for the quarter ended June 30, 1988 on August 25, 1988 and incorporated herein by
reference.)
10.22 Assignment and License Agreement, dated October 16, 1986 (effective July 1, 1986, between
Amgen and Kirin-Amgen, Inc. (Filed as an exhibit to Form 10-K for the year ended December 31,
2000 on March 7, 2001 and incorporated herein by reference.)
10.23 G-CSF United States License Agreement, dated June 1, 1987 (effective July 1, 1986), Amendment
No. 1, dated October 20, 1988, and Amendment No. 2, dated October 17, 1991 (effective
November 13, 1990), between Kirin-Amgen, Inc. and Amgen Inc. (Filed as exhibits to Form 10-K
for the year ended December 31, 2000 on March 7, 2001 and incorporated herein by reference.)
99